BI
COGT icon

BVF Inc’s Cogent Biosciences COGT Stock Holding History

BVF Inc’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-984,824
Closed -$11.4M – 74
2022
Q4 		$11.4M Sell
984,824
-1,100,000
-53% -$13.6M 0.48% 48
2022
Q3 		$31.1M Sell
2,084,824
-172,350
-8% -$2.36M 1.28% 28
2022
Q2 		$20.4M Buy
2,257,174
+724,892
+47% +$4.95M 0.98% 31
2022
Q1 		$11.5M Hold
1,532,282
– – 0.46% 54
2021
Q4 		$13.1M Hold
1,532,282
– – 0.48% 50
2021
Q3 		$12.9M Hold
1,532,282
– – 0.5% 50
2021
Q2 		$12.4M Hold
1,532,282
– – 0.47% 48
2021
Q1 		$13.5M Hold
1,532,282
– – 0.5% 43
2020
Q4 		$17.2M Buy
+1,532,282
New +$16.8M 0.68% 37

Other funds holding COGT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc's COGT Position: Q1 2023 in Review

BVF Inc sold out of Cogent Biosciences (COGT) in Q1 2023, closing a stake of 984,824 shares — an estimated $11.4M sold.

BVF Inc first reported a position in COGT in Q4 2020 and held it in 9 quarters. The position peaked at $31.1M in Q3 2022. 136 funds tracked by Wall St. Rank hold COGT as of Q1 2023.

  • BVF Inc reported no remaining Cogent Biosciences position as of Q1 2023 after selling out during the quarter.
  • BVF Inc sold 984,824 Cogent Biosciences shares in Q1 2023, an estimated $11.4M.
  • BVF Inc first reported a position in Cogent Biosciences in Q4 2020 and held it in 9 quarters.
  • BVF Inc's Cogent Biosciences position peaked at $31.1M in Q3 2022.
  • 136 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2023.

Based on BVF Inc's 13F filing for Q1 2023, filed 15 May 2023.